Ofloxacin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ofloxacin and what is the scope of freedom to operate?
Ofloxacin
is the generic ingredient in six branded drugs marketed by Ortho Mcneil Pharm, Bedford, Allergan, Altaire Pharms Inc, Alvogen, Amneal, Apotex Inc, Bausch And Lomb, Caplin, Epic Pharma Llc, Fdc Ltd, Mankind Pharma, Sandoz, Sentiss, Somerset, Daiichi, Hikma, Janssen Pharms, Cadila Pharms Ltd, Chartwell Rx, Dr Reddys Labs Ltd, Ranbaxy Labs Ltd, and Teva, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.There are seventy-eight drug master file entries for ofloxacin. Thirty-one suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for ofloxacin
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 23 |
NDAs: | 32 |
Drug Master File Entries: | 78 |
Finished Product Suppliers / Packagers: | 31 |
Raw Ingredient (Bulk) Api Vendors: | 167 |
Clinical Trials: | 37 |
Patent Applications: | 6,459 |
Drug Prices: | Drug price trends for ofloxacin |
Drug Sales Revenues: | Drug sales revenues for ofloxacin |
What excipients (inactive ingredients) are in ofloxacin? | ofloxacin excipients list |
DailyMed Link: | ofloxacin at DailyMed |
Recent Clinical Trials for ofloxacin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
IVIEW Therapeutics Inc. | Phase 2 |
Jagiellonian University | N/A |
Centre Hospitalier Universitaire, Amiens | N/A |
Generic filers with tentative approvals for OFLOXACIN
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 400MG | TABLET;ORAL |
⤷ Sign Up | ⤷ Sign Up | 300MG | TABLET;ORAL |
⤷ Sign Up | ⤷ Sign Up | 200MG | TABLET;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for ofloxacin
Drug Class | Quinolone Antimicrobial |
Medical Subject Heading (MeSH) Categories for ofloxacin
Anatomical Therapeutic Chemical (ATC) Classes for ofloxacin
US Patents and Regulatory Information for ofloxacin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | OFLOXACIN | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 211524-001 | Mar 1, 2024 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ranbaxy Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 076220-001 | Sep 2, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dr Reddys Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 077098-003 | Feb 10, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alvogen | OFLOXACIN | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 076830-001 | Aug 31, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | OFLOXACIN | ofloxacin | TABLET;ORAL | 076182-003 | Sep 2, 2003 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ranbaxy Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 076220-002 | Sep 2, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bedford | OFLOXACIN | ofloxacin | INJECTABLE;INJECTION | 075762-001 | Jan 16, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ofloxacin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ortho Mcneil Pharm | FLOXIN | ofloxacin | INJECTABLE;INJECTION | 020087-002 | Mar 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-004 | Mar 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-005 | Mar 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Daiichi | FLOXIN OTIC | ofloxacin | SOLUTION/DROPS;OTIC | 020799-001 | Dec 16, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | OCUFLOX | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 019921-001 | Jul 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | FLOXIN | ofloxacin | TABLET;ORAL | 019735-001 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | FLOXIN | ofloxacin | TABLET;ORAL | 019735-003 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.